Matthew Flick: New Evidence on SARS-CoV-2 Spike Protein and Clot Formation
Matthew Flick, Professor at University of North Carolina at Chapel Hill, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
”I’m excited to report that our latest publication is now available online in Blood Advances – Blood Journals Portfolio.
Here we provide data supporting the idea that the SARS-CoV-2 spike protein conditionally binds fibrin(ogen), but we refute the concept that it influences plasma clot fibrin formation, structure, or lysis.
Outstanding work by lead author Kadri Kangro. Another amazing collaboration with my colleague Alisa Wolberg and her team, namely Samer Issa.”
Title: SARS-CoV-2 spike protein can bind fibrin(ogen), but does not alter plasma fibrin formation, clot structure, or lysis
Authors: Kadri Kangro, Samer M Issa, Alisa S. Wolberg, Matthew J. Flick
Read the Full Article on Blood Advances
Stay updated with Hemostasis Today.
-
May 12, 2026, 16:46Tagreed Alkaltham: Why Apheresis Matters in Modern Transfusion Medicine
-
May 12, 2026, 16:37Reinhold Kreutz: Cardiovascular Burden in Acute Intermittent Porphyria Needs Greater Awareness
-
May 12, 2026, 16:33Pablo Corral: The Truth About Very Low LDL-Cholesterol
-
May 12, 2026, 16:24Mildred Lundgren: We Must Talk About the Invisible Causes of Stroke
-
May 12, 2026, 16:17Irene Scala: The Sex Disparities In Access to Acute Stroke Treatments In Italy
-
May 12, 2026, 16:04May Nour: UCLA Health Mobile Stroke Unit Becomes The 1st In The World to Perform mCTA In the Field
-
May 12, 2026, 15:57Leonardo Roever: Prognostic Impact of Lipoprotein(a) and CAR in Elderly Acute Ischemic Stroke Patients
-
May 12, 2026, 15:54Bruno Pougault: Prioritizing Laboratory Tests in Resource-Limited Emergency Care
-
May 12, 2026, 15:37Jennifer Holter Chakrabarty: Supporting the Next Generation of Hematology Researchers